Paull Robert Bradley 4
4 · Kala Pharmaceuticals, Inc. · Filed Jun 7, 2019
Insider Transaction Report
Form 4
Paull Robert Bradley
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2019-06-05+21,000→ 21,000 totalExercise: $5.35Exp: 2029-06-04→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 5, 2019 and vests with respect to 1/12th of the shares underlying the option at the end of each successive one-month period thereafter.